1. Home
  2. GAUZ vs BLRX Comparison

GAUZ vs BLRX Comparison

Compare GAUZ & BLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gauzy Ltd. Ordinary Shares

GAUZ

Gauzy Ltd. Ordinary Shares

HOLD

Current Price

$0.68

Market Cap

13.6M

Sector

Miscellaneous

ML Signal

HOLD

Logo BioLineRx Ltd.

BLRX

BioLineRx Ltd.

HOLD

Current Price

$3.07

Market Cap

12.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GAUZ
BLRX
Founded
2009
2003
Country
Israel
Israel
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.6M
12.6M
IPO Year
2019
2010

Fundamental Metrics

Financial Performance
Metric
GAUZ
BLRX
Price
$0.68
$3.07
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$11.50
$19.00
AVG Volume (30 Days)
40.2K
14.7K
Earning Date
05-12-2026
05-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$22.59
N/A
Revenue Next Year
$59.03
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.48
$2.15
52 Week High
$10.01
$7.77

Technical Indicators

Market Signals
Indicator
GAUZ
BLRX
Relative Strength Index (RSI) 46.47 73.89
Support Level $0.67 $2.66
Resistance Level $0.88 $3.11
Average True Range (ATR) 0.06 0.17
MACD -0.00 0.07
Stochastic Oscillator 12.66 91.80

Price Performance

Historical Comparison
GAUZ
BLRX

About GAUZ Gauzy Ltd. Ordinary Shares

Gauzy Ltd is a fully integrated light and vision control company. Its products include suspended particle device and liquid crystal materials for smart glass applications and AI-powered driver assistance systems, or ADAS, solutions including camera monitoring systems. The company's operating segments are Architecture, Automotive, Safety tech, and Aeronautics. Maximum revenue is generated from its Safety tech segment, which focuses on sales of driver assistance systems for buses, coaches, recreational vehicles, and specific vehicles, such as camera and motion sensor systems, smart mirrors, and safety doors. Geographically, it derives maximum revenue from other European countries (excluding France), followed by the United States, France, Asia, Israel, and other regions.

About BLRX BioLineRx Ltd.

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

Share on Social Networks: